(NYSE: BSX) Boston Scientific's forecast annual revenue growth rate of 9.52% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.89%.
Boston Scientific's revenue in 2025 is $18,494,000,000.On average, 11 Wall Street analysts forecast BSX's revenue for 2025 to be $29,346,073,330,350, with the lowest BSX revenue forecast at $28,946,018,170,190, and the highest BSX revenue forecast at $29,550,572,836,862. On average, 11 Wall Street analysts forecast BSX's revenue for 2026 to be $32,577,791,425,124, with the lowest BSX revenue forecast at $32,025,098,065,642, and the highest BSX revenue forecast at $33,123,076,026,436.
In 2027, BSX is forecast to generate $36,052,427,882,776 in revenue, with the lowest revenue forecast at $35,532,033,745,412 and the highest revenue forecast at $37,095,652,157,190.